On October 11, AstraZeneca met the primary endpoint of their antibody combination that can be used to treat and prevent COVID-19. They have discovered that receiving an intramuscular injection of AZD7442 within five days of having COVID-19 symptoms can reduce the risk of dying by 50%. Currently, the AstraZeneca lab is the only lab that […]
